echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The State Food and Drug Administration has cancelled 223 drugs, many of which are multinational pharmaceutical companies such as GlaxoSmithKline and Pfizer

    The State Food and Drug Administration has cancelled 223 drugs, many of which are multinational pharmaceutical companies such as GlaxoSmithKline and Pfizer

    • Last Update: 2022-05-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [Pharmaceutical Network Industry News] On April 18, the website of the State Food and Drug Administration released the "Announcement of the State Food and Drug Administration on Cancellation of 223 Drug Registration Certificates such as Rosiglitazone Maleate Tablets (No.
    34 of 2022)"
    .

    According to the content of the announcement, in accordance with the relevant provisions of the "Implementation Regulations of the Drug Administration Law of the People's Republic of China" and the "Administrative Measures for Drug Registration", the State Drug Administration has decided to cancel 223 drug registration certificates including rosiglitazone maleate tablets
    .

    A total of 143 drugs have been cancelled this time, including rosiglitazone maleate tablets, cimetidine tablets, prednisone acetate tablets, compound acetylsalicylic acid tablets, oxytetracycline tablets, and glipizide.
    Tablets, cefoperazone sodium for injection and other large varieties, also include many varieties such as glipizide tablets, azithromycin tablets, cephalexin capsules, etc.
    that have been included in the national centralized procurement
    .

    For example, the cancelled drug registration certificates include GlaxoSmithKline (Tianjin) Co.
    , Ltd.
    's rosiglitazone maleate tablets, approved by Chinese medicine H20031082, and approved by Chinese medicine H20020475; hypromellose eye drops, approved by Chinese medicine H20043228, Oxymetazoline Hydrochloride Eye Drops is approved by Chinese medicine H20083737
    .

    Sino-US Tianjin SmithKline Pharmaceutical Co.
    , Ltd.
    Cimetidine Tablets is approved by Chinese medicine H12020499 and Chinese medicine is approved by H12020498
    .

    Tianjin Pacific Pharmaceutical Co.
    , Ltd.
    Prednisone Acetate Tablets National Medicine Certificate H12020809; Dexamethasone Acetate Tablets National Medicine Certificate H12020293; Methyltestosterone Tablets National Medicine Certificate H12020792
    .

    Tianjin Tanabe Pharmaceutical Co.
    , Ltd.
    Ecabet Sodium Granules approved by Chinese medicine H20103124
    .

    Inner Mongolia Haitian Pharmaceutical Co.
    , Ltd.
    Analgin Tablets National Medicine Certificate H15020986; Compound Sulfadiazine Tablets National Medicine Certificate H15020988; Compound Acetylsalicylic Acid Tablets National Medicine Certificate H15020989; Sulfamidine Tablets National Medicine Certificate H15020992; Chloramphenicol tablets are approved by H15020283; Tetracycline tablets are approved by H15020927; Oxytetracycline tablets are approved by H15020929
    .

    Pfizer Pharmaceuticals Co.
    , Ltd.
    Glipizide Tablets National Medicine Certificate H20054471; Azithromycin Tablets National Medicine Certificate H10960168; Cefoperazone Sodium for Injection National Medicine Certificate H21021895, Chinese Medicine Certificate H19994141
    ;
       A total of 31 manufacturing companies have applied for cancellation, including many multinational companies such as GlaxoSmithKline, Pfizer, and Allergan
    Inc.

    In addition, according to the review, Ningxia Qiyuan National Pharmaceutical Co.
    , Ltd.
    has cancelled 101 drug registration certificates this time, including vitamin B1 calcium chewable tablets, calcium lactate tablets, calcium gluconate tablets, compound theophylline ephedrine tablets, etc.
    ; Suzhou Yifan Pharmaceutical Co.
    , Ltd.
    Co.
    , Ltd.
    has 20 drug registration certificates cancelled this time, including Qutong Tablets, Furazolidone Tablets, Furazolidone Tablets, etc.
    ; Hainan Boda Pharmaceutical Factory has cancelled 18 drug registration certificates this time; Hainan General Union Pharmaceutical Co.
    , Ltd.
    has 14; 10 Ningxia Kangya Pharmaceutical Co.
    ,
    Ltd.

       It is reported that most of the products cancelled by Ningxia Qiyuan this time were approved in 2014.
    This cancellation is all overdue and legally cancelled, which will not affect the production and operation of the enterprise
    .

       After the drug is cancelled, the enterprise will not be allowed to produce the drug before a new registration certificate is approved
    .

     Screenshots of some canceled products Complete canceled list: see related data download below
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.